1. Technical Field
This invention relates to a medical device and, in particular, a prosthesis for implantation within the human or animal body for the repair of an aneurism, dissection, or intramural hematoma within a lumen, and a method for implanting the same.
2. Related Art
Throughout this specification, when discussing the aorta or other blood vessels, the terms distal and distally with respect to a prosthesis are intended to refer to the end of the prosthesis furthest away in the direction of blood flow from the heart. Similarly, the terms proximal and proximally are intended to mean the end of the prosthesis which, when implanted, would be nearest to the heart.
The functional vessels of humans, such as blood vessels and ducts, occasionally weaken or even rupture. For example, the aortic wall can weaken, resulting in an aneurysm Upon further exposure to haemodynamic forces, such an aneurysm can rupture. A common surgical intervention for weakened, aneurismal or ruptured vessels is the use of a prosthesis to provide some or all of the functionality of the original, healthy vessel and/or preserve any remaining vascular integrity by replacing a length of the existing vessel wall that spans the site of vessel failure.
The deployment of intraluminal prostheses into the lumen of a patient from a remote location by the use of a deployment device or introducer has been disclosed in a number of earlier patents, published patent applications, and other publications. U.S. Pat. No. 4,562,596, entitled “Aortic Graft, Device and Method for Performing an Intraluminal Abdominal Aortic Aneurysm Repair” which is herein incorporated by reference, proposes the retention of a self expanding graft within a sleeve until it is to be deployed, at which time the sleeve is withdrawn and the graft is allowed to expand. U.S. Pat. No. 4,665,918, entitled “Prosthesis System and Method” which is herein incorporated by reference, proposes a system and method for the deployment of a prosthesis in a blood vessel. The prosthesis is positioned between a delivery catheter and an outer sheath and expands outwardly upon removal of the sheath.
U.S. Pat. No. 4,950,227, entitled “Stent Delivery System” which is herein incorporated by reference, proposes the delivery of a stent by mounting the stent to the outside of an inflatable catheter and retaining the ends of an unexpanded stent by fitting a sleeve over either end of the stent. Expansion of the stent is caused by inflation of the catheter between the sleeves so that the ends of the stent are withdrawn from the respective sleeves and the stent released and expanded into position.
Other clinical approaches to aneurysm repair known as endovascular grafting have been proposed. (See, Parodi, J. C., et al. “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms,” 5 Annals of Vascular Surgery, 491 (1991)). Endovascular grafting involves the transluminal placement of a prosthetic arterial graft in the endoluminal position within the lumen of the artery. By this method, the graft is attached to the internal surface of an arterial wall by means of attachment devices such as expandable stents, a cephalic stent above the aneurysm and a caudal stent below the aneurysm.
U.S. Pat. No. 5,387,235 entitled “Expandable Transluminal Graft Prosthesis for Repair of Aneurysm”, discloses apparatus and methods of retaining grafts onto deployment devices. These features and other features disclosed in U.S. Pat. No. 5,387,235 could be used with the present invention and the disclosure of U.S. Pat. No. 5,387,235 is herein incorporated by reference.
U.S. Pat. No. 5,720,776 entitled “Barb And Expandable Transluminal Graft Prostheses for Repair of Aneurysm” discloses improved barbs with various forms of mechanical attachment to a stent. These features and other features disclosed in U.S. Pat. No. 5,720,776 could be used with the present invention and the disclosure of U.S. Pat. No. 5,720,776 is herein incorporated by reference.
U.S. Pat. No. 6,206,931 entitled “Graft Prosthesis Materials” discloses graft prosthesis materials and a method for implanting, transplanting replacing and repairing a part of a patient and particularly the manufacture and use of a purified, collagen based matrix structure removed from a submucosa tissue source. These features and other features disclosed in U.S. Pat. No. 6,206,931 could be used with the present invention and the disclosure of U.S. Pat. No. 6,206,931 is herein incorporated by reference.
PCT Patent Publication Number No. WO99/29262 entitled “Endoluminal Aortic Stents” discloses a fenestrated prosthesis for placement where there are intersecting arteries. This feature and other features disclosed in PCT Patent Publication Number No. WO99/29262 could be used with the present invention and the disclosure of PCT Patent Publication Number No. WO99/29262 is herein incorporated by reference.
PCT Patent Publication Number No. WO03/034948 entitled “Prostheses for Curved Lumens” discloses prostheses with arrangements for bending the prosthesis for placement into curved lumens. This feature and other features disclosed in PCT Patent Publication Number No. WO03/034948 could be used with the present invention and the disclosure of PCT Patent Publication Number No. WO03/034948 is herein incorporated by reference.
United States Patent Application Publication No. 20030233140 entitled “Trigger Wire System” discloses release wire systems for the release of stent grafts retained on introducer devices. This feature and other features disclosed in United States Patent Application Publication No. 20030233140 could be used with the present invention and the disclosure of United States Patent Application Publication No. 20030233140 is herein incorporated by reference.
United States Patent Application Publication No. 20040098079 entitled “Thoracic Aortic Stent Graft Deployment Device” discloses introducer devices adapted for deployment of stent grafts particularly in the thoracic arch. This feature and other features disclosed in United States Patent Publication No. 20040098079 could be used with the present invention and the disclosure of United States Patent Publication No. 20040098079 is herein incorporated by reference.
United States Patent Application Publication No. 20040054396 entitled “Stent-Graft Fastening” discloses arrangements for fastening stents onto grafts particularly for exposed stents. This feature and other features disclosed in United States Patent Application Publication No. 20040054396 could be used with the present invention and the disclosure of United States Patent Application Publication No. 20040054396 is herein incorporated by reference.
PCT Patent Publication Number No. WO03/053287 entitled “Stent Graft With Improved Graft Adhesion” discloses arrangements on stent grafts for enhancing the adhesion of such stent grafts into walls of vessels in which they are deployed. This feature and other features disclosed in PCT Patent Publication Number No. WO03/053287 could be used with the present invention and the disclosure of PCT Patent Publication Number No. WO03/053287 is herein incorporated by reference.
PCT Patent Publication Number No. WO98/53761 entitled “A Prosthesis and a Method of Deploying a Prosthesis”, which is herein incorporated by reference, discloses various embodiments of an introducer for positioning an expandable endovascular prosthesis in a lumen of a patient.
One issue that arises with the use of an intraluminal prosthesis is where the damage in a vessel is at or near an angled or curved portion of the lumen, such as, for example, the aortic arch. In these instances, the intraluminal prosthesis may have an increased tendency to leak. It would be desirable to provide an intraluminal prosthesis with a sealing means that provides an effective seal in an angled or curved portion of a lumen.
An intraluminal prosthesis for strengthening a lumen is provided having particular utility in angulated anatomy. The prosthesis includes a tubular graft comprising a hollow body sufficiently flexible to conform to a targeted angulated anatomy. A self-expanding stent can be coupled to the body that provides enough outward radial force to expand at least a portion of the hollow flexible body. The self-expanding stent can include gripping means for gripping the walls of the lumen to hold at least a portion of the prosthesis at or adjacent to the targeted anatomy. The prosthesis can also include a tubular stent. The tubular stent can have a first diameter and a second expanded diameter. The tubular stent can be self expanding between the first and second diameter, or formable to the second diameter by application of an outwardly extending force from the interior of the tubular stent. The second diameter is desirably at least equal to the interior diameter of the targeted anatomy in which the intraluminal prosthesis is to be employed. Other features and advantages of an intraluminal prosthesis of the present invention will become apparent from the following detailed description.
The term “prosthesis” means any replacement for a body part or function of that body part. It can also mean a device that enhances or adds functionality to a physiological system. The terms “intraluminal” and “endoluminal” describes objects that are found or can be placed inside a lumen in the human or animal body. A lumen can be an existing lumen or a lumen created by surgical intervention. This includes lumens such as blood vessels, parts of the gastrointestinal tract, ducts such as bile ducts, parts of the respiratory system, etc. “endoluminal prosthesis” or “intraluminal prosthesis” thus describes a prosthesis that can be placed inside one of these lumens.
The invention can be better understood with reference to the following drawings and description. The components in the Figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, in the Figures, like referenced numerals designate corresponding parts throughout the different views.
A cutaway view of a prosthesis 20 of the present invention is shown in
The material forming the tubular graft 50 is preferably non-porous so that the tubular graft 50 does not leak or sweat under physiologic forces. The graft material can be made of woven DACRON® polyester (VASCUTEK® Ltd., Renfrewshire, Scotland, UK). The tubular graft 50 can also be made of any other at least substantially biocompatible material including such materials as other polyester fabrics, polytetrafluoroethylene (PTFE), expanded PTFE, and other synthetic materials known to those of skill in the art. Naturally occurring biomaterials, such as collagen, are also highly desirable for forming the tubular graft 50, particularly a derived collagen material known as extracellular matrix (ECM), such as small intestinal submucosa (SIS).
Other examples of ECMs suitable for forming tubular graft 50 are pericardium, stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater. SIS is particularly useful, and can be made in the fashion described in U.S. Pat. No. 4,902,508 to Badylak et al.; U.S. Pat. No. 5,733,337 to Carr; 17 Nature Biotechnology 1083 (November 1999); and WIPO Publication WO 98/22158 of May 28, 1998, to Cook et al., which is the published application of PCT/US97/14855. All of these patents and publications are incorporated herein by reference.
Irrespective of the origin of the material for the tubular graft 50 (synthetic versus naturally occurring), the graft material can be made thicker by making multi-laminate constructs, for example SIS constructs as described in U.S. Pat. No. 5,968,096, U.S. Pat. No. 5,955,110, U.S. Pat. No. 5,885,619, and U.S. Pat. No. 5,711,969. All of these patents are incorporated herein by reference. In addition to xenogenic biomaterials, such as SIS, autologous tissue can be harvested as well, for use in forming the graft material. Additionally elastin or elastin-like polypeptides (ELPs) and the like offer potential as a material to fabricate the tubular graft 50.
The prosthesis 20 can include self expanding stents 19 that cause the prosthesis 20 to expand following its disengagement from a suitable introducer. The prosthesis 20 can also include a self expanding zigzag stent 18 that extends from a proximal end 51 of the tubular graft 50. The self expanding zigzag stent 18 can have gripping means in the form of hooks or barbs 23 to anchor at least the proximal end 51 of the tubular graft 50 to a selected location within a lumen in a patients body. As shown in the cutaway portion of
The external manipulation section 1 includes a body 36 that is mounted onto a thick walled plastic tube 41. A thin walled tube 15 passes through the body 36. A connector 16 on the end of the thin walled tube 15 is adapted to accept a syringe to facilitate the introduction of reagents into the tube 15. A proximal wire release mechanism 24 is mounted for slidable movement on the body 36. Similarly, a distal wire release mechanism 25 is mounted for slidable movement on the body 36. A pair of clamping screws 37 prevents inadvertent movement of the wire release mechanisms 24 and 25 relative to the body 36. A pin vise 39 is mounted onto the distal end of the body 36 that has a screw cap 46 that controls the movement of thin walled tube 15 with respect to the body 36. A clamping collar 26 surrounds the thick wall plastic tube 41. A sheath 30 surrounds the thick wall plastic tube 41 and is coupled to the clamping collar 26 that is fixed to a haemostatic sealing assembly 35. A side tube 29 on the sealing assembly 35 facilitates the introduction of medical reagents between the thick walled tube 41 and the sheath 30.
The proximal positioning mechanism and attachment region 3 includes a cylindrical sleeve 10 and a long tapered flexible extension 11, which are shown in greater detail in
The distal positioning mechanism and attachment region 2 is shown in detail in
The sheath 30 is longitudinally movable with respect to the thick walled plastic tube 41 by manipulation of the clamping collar 26. The haemostatic sealing assembly 35 includes a chamber 27 and the side tube 29. The clamping collar 26 engages the proximal end of chamber 27 and clamps the sheath 30 to the chamber 27. A seal ring 28, typically made of silicone, is coupled to the distal end of the chamber 27 by a compression fitting 34 that ensures a haemostatic seal around the thick walled tube 41. The side tube 29 facilitates the introduction of medical reagents between the thick walled tube 41 and the sheath 30.
The release wire actuation section 32 of the external manipulation section 1 is shown in
The release wire 22 extends forward from the proximal wire release mechanism 24 through a space between the thin walled tube 15 and the thick walled plastic tube 41, and through the interior of the prosthesis 20 to the junction between the cylindrical sleeve 10 and the tapered flexible extension 11 as shown in
The release wire 44 extends forward from the proximal wire release mechanism 25 through the space between the thin walled tube 15 and the thick walled plastic tube 41. The release wire 44 extends through a loop 43 in the distal end 42 of the prosthesis 20 as shown in
During assembly of the combined introducer 5 and prosthesis 20, the sheath 30 is advanced over the cylindrical sleeve 10 of the proximal attachment region 3 while the prosthesis 20 is held in a compressed state by an external force. During the placement phase, the prosthesis 20 is retained in a compressed condition by the sheath 30, the sheath 30 extending proximally beyond the proximal end 31 of the thick walled plastic tube 41 to mate with the cylindrical sleeve 10 as shown in
The prosthesis 20 can be deployed in any method known in the art, preferably the method described in WO98/53761 in which the devise is inserted by the introducer 5 via a surgical cut-down into a femoral artery, and then advanced into the desired position over a stiff wire guide 13 using endoluminal interventional techniques. For example,
The prosthesis 20 is then released by first retracting the sheath 30. The retraction is accomplished by moving the gripping collar 26 and haemostatic sealing assembly 35 distally along the thick walled tube 41 to the position shown in
Next, the release wire 22 is pulled from its connection between the tapered flexible extension 11 and the proximal end of the thin walled tube 15. This is accomplished by releasing the clamping screw 37 holding the proximal wire release mechanism 24 to the body 36, and then sliding the proximal wire release mechanism 24 off the distal end of the external manipulation section 1. This frees the attachment region 3, including the cylindrical sleeve 10, for movement proximally away from the prosthesis 20. This movement is accomplished by releasing the screw cap 46 of the pin vise 39 so that the thin walled tubing 15 can been pushed in a proximal direction to move the cylindrical sleeve 10 in a proximal direction. When the cylindrical sleeve 10 no longer surrounds the self-expanding stent 18 at the proximal end of the prosthesis 20, the self-expanding stent 18 expands as shown in
At this point, the distal end 42 of the prosthesis 20 is still retained by the distal attachment section 40 as shown in
Next, the distal release wire 44 is removed and the distal end 42 of the prosthesis 20 released as shown in
The first stage of removal is shown in
An alternate embodiment of a prosthesis 21 is shown in
The sleeve 116 may be substantially the same length as the catheter 112 and include a proximal end 138 fixed to the catheter 112, for example, fixed near the proximal end 130 of the catheter 112 at the coupling 134. The sleeve 116 can be composed of any of a variety of materials, some more suited to particular applications than others. The sleeve 116 may be composed of an indistensable material. The sleeve 116 may also be composed of a medical grade material, which can be either physiologically inert or biodegradable. Although not depicted, another lumen extends longitudinally through the catheter between the distal end thereof and one of the proximal couplings 132. This lumen is typically utilized for passing the catheter over a wire guide that has already been positioned in a vessel.
Inflation of the balloon with the fluids need only proceed for the balloon to extend radially outwardly to expand the sleeve. Preferably, the wire stent 17 is expanded by expansion of the balloon 122 during its inflation by the fluid. Once the wire stent 17 has been expanded, the balloon 122 may be deflated, and the introducer 100 can be removed from the lumen.
Throughout this specification, unless the context requires otherwise, the words “comprise” and “include” and variations such as “comprising” and “including” will be understood to imply the inclusion of an item or group of items, but not the exclusion of any other item or group items.
While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that many more embodiments and implementations are possible within the scope of the invention. Furthermore, although various indications have been given as to the scope of this invention, the invention is not limited to any one of these but may reside in two or more of these combined together. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US05/23491 | 6/30/2005 | WO | 8/16/2007 |
Number | Date | Country | |
---|---|---|---|
60585314 | Jul 2004 | US |